Picture of Choong Ang Vaccine Laboratory logo

072020 Choong Ang Vaccine Laboratory Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Choong Ang Vaccine Laboratory, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,1647,6024,0445,9986,850
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1,720-1,6981,7742,240542
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-958616-4,787-1,045472
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities8,31611,5257,08612,70613,402
Capital Expenditures-15,404-14,366-7,170-1,918-7,170
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,2562,366-2,012-1,505-2,848
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-13,148-12,000-9,181-3,423-10,018
Financing Cash Flow Items0.859
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3,929-877-1,600-2,813-4,778
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,116-944-3,4896,541-926